Smith & Nephew PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Smith & Nephew plc - ADR: Is Infosys Ltd. worth buying?
Item: Smith & Nephew plc - ADR
Rating: 1.55516675
Author: Trendlyne DVM scores

about

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medici...

32.63 -0.16 (-0.49%)

37.74% Gain from 52W Low

804.0K

XNYS Volume

XNYS 12 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

9.2 / 100

Technically Neutral

53.0 / 100

1Yr Price target upside is 12%

5 analysts

Smith & Nephew PLC (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Smith & Nephew PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medici...

37.74% Gain from 52W Low

SWOT Analysis

Smith & Nephew PLC (ADR) Live Price Chart